Appili Therapeutics Inc has seen a dramatic drop in its stock price, raising concerns among investors.
In today's trading session, Appili Therapeutics Inc (APLI.TO) is experiencing a significant decline, with shares plummeting by 33.33%. This downturn has left investors questioning the company's future prospects amidst a lack of recent news and developments.
Investor takeaway: The sharp decline in Appili's stock price highlights the volatility and risks associated with investing in small-cap biotech firms, especially when market sentiment turns negative.
Advertisement
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeAdvertisement
Market cap
$1.99M
52W high
$0.04
52W low
$0.01
1W change
+0.00%
Beta
-0.20
Analyst Price Targets
Based on analyst covering APLI
Wall Street analysts forecast APLI stock price to rise 1400.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+1400.0% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
266.4%
Annualized
90-Day Vol
252.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.00 – C$0.02 |
| 60 trading days | C$0.01 | C$0.00 – C$0.03 |
| 90 trading days | C$0.01 | C$0.00 – C$0.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Appili's stock price drops to CA$0.01
With a market cap of approximately CA$1.32 million, Appili's stock is now at a critical low, raising concerns about its financial stability.
Bull case
If Appili can secure additional funding or show progress in its product pipeline, there might be a chance for its stock price to recover.
Bear case
Without any recent positive news or developments, the ongoing decline in investor confidence could lead to further losses for Appili's stock.
Market Reaction
Advertisement
The steep decline of 33.33% in Appili's stock price today has raised eyebrows among investors. With shares closing at just CA$0.01, the market cap has now shrunk to approximately CA$1.32 million. The lack of recent positive developments or news from the company has contributed to this negative sentiment.
Investor Sentiment
Investors are worried about the company's future as Appili has not released any significant updates or news lately. This absence of information can lead to increased volatility and uncertainty, prompting many to rethink their positions. For more insights on Appili's performance, visit our stock page.
Looking Ahead
As Appili Therapeutics navigates this challenging period, investors will be closely watching for any announcements that could impact stock performance. The biotech sector can be particularly unpredictable, making it essential for investors to stay informed. For more details on Appili's stock and potential developments, check our analysis.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
